Update IBD and COVID-19

As of March 27th 117 patients with either Crohn's or ulcerative colitis have been identified as being infected with Covid-19

Cases and outcomes by disease type

  Number of cases (n) Outpatient only (n,%) Hospitalized (n,%) ICU (n,%) Ventilator (n,%) Death (n,%) ICU/Ventilator/Death (n,%)
Crohn's disease  67 55 82% 11 16% 1 1% 1 1% 2 3% 3 4%
Ulcerative Colitis  48 35 73% 13 27% 1 2% 1 2% 3 6% 3 6%
IBD-unspecified  2 2 100% 0 0% 0 0% 0 0% 0 0% 0 0%


Any conclusion about the what we no so far is extremely speculative as this is a very small sample but what appears to be the case so far: 

The overall mortality rate is not strikingly different from the general population.  Risk factors for having a more severe course are, as expected: being on multiple immunosupressant drugs, for example remicade or humira plus 6mp or methotrexate, or steroids such as prednisone.

Please be extremely careful,  if you are any any of these drugs:  Remicade, Humira, Cimzia, Simponi, Stelara, Xeljanj, Entyvio, 6MP, Imuranor methotrexate be extremely careful to follow all CDC guidelines about social distancing and meticulous handwashing if you are going out of your home an touching anything.  Stay at home as much as possible.  If you are on any combination of the above or taking any of these medications plus steroids I would advise not going outside at all if possible and quarantine yourself from anyone who might come has had any known contact with a coronovirus patient in the past 14 days.


You Might Also Enjoy...